WOLVERINE TRADING, LLC - PROTALIX BIOTHERAPEUTICS INC ownership

PROTALIX BIOTHERAPEUTICS INC's ticker is PLX and the CUSIP is 74365A309. A total of 33 filers reported holding PROTALIX BIOTHERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.25 and the average weighting 0.0%.

Quarter-by-quarter ownership
WOLVERINE TRADING, LLC ownership history of PROTALIX BIOTHERAPEUTICS INC
ValueSharesWeighting
Q2 2023$378,031
+2100072.2%
174,208
+1240.1%
0.00%
Q4 2022$18
-99.9%
13,000
+8.3%
0.00%
Q2 2022$13,000
-53.6%
12,000
-63.3%
0.00%
Q4 2021$28,000
-83.4%
32,700
-73.4%
0.00%
Q3 2021$169,000
-46.7%
123,068
-25.8%
0.00%
Q2 2021$317,000
+3.6%
165,806
+144.2%
0.00%
Q1 2021$306,000
+705.3%
67,898
+524.2%
0.00%
Q4 2020$38,000
-17.4%
10,878
-7.8%
0.00%
Q3 2020$46,000
-16.4%
11,800
-49.4%
0.00%
Q1 2020$55,00023,3000.00%
Other shareholders
PROTALIX BIOTHERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Burrage Capital Management LLC 2,470,332$8,967,0006.83%
Psagot Value Holdings Ltd. 470,255$1,707,0000.04%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 212,591$772,0000.02%
UBS OCONNOR LLC 150,000$544,000,0000.01%
GSA CAPITAL PARTNERS LLP 10,042$36,0000.01%
Renaissance Technologies 488,634$1,774,0000.00%
Squarepoint Ops LLC 22,068$80,0000.00%
BANK OF AMERICA CORP /DE/ 222$1,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GROUP ONE TRADING, L.P. 50,280$183,0000.00%
View complete list of PROTALIX BIOTHERAPEUTICS INC shareholders